Progressive and sustained improvements in the extent and severity of atopic dermatitis with tralokinumab in combination with topical corticosteroids as needed in moderate-to-severe atopic dermatitis

被引：0
|
作者：
Alexis, A. F. [1 ]
Zirwas, M. [2 ]
Pinter, A. [3 ]
Adam, D. N. [4 ,5 ]
Chiricozzi, A. [6 ,7 ]
Pink, A. E. [8 ]
Mark, T. [9 ]
Tindberg, A. M. [9 ]
Silverberg, J. I. [10 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA
[2] Prob Med Res, Columbus, OH USA
[3] Univ Hosp Frankfurt Main, Clin Dermatol Venereol & Allergol, Frankfurt, Germany
[4] CCA Med Res, Ajax, ON, Canada
[5] Univ Toronto, Temerty Fac Med, Div Dermatol, Toronto, ON, Canada
[6] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Med & Chirurg, Dermatol, Rome, Italy
[7] Univ Cattolica Sacro Cuore, Dermatol, Rome, Italy
[8] Guys & St Thomas Hosp, St Johns Inst Dermatol, London, England
[9] LEO Pharma AS, Ballerup, Denmark
[10] George Washington Univ, Sch Med & Hlth Sci, Dept Dermatol, Washington, DC 20052 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 184卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
384
引用
收藏
页码：E82 / E83
页数：2
相关论文
共 50 条
  • [21] Topical corticosteroids for atopic dermatitis
    Braschi, Emelie
    Young, Jennifer
    Allan, G. Michael
    CANADIAN FAMILY PHYSICIAN, 2024, 70 (09) : 558 - 558
  • [22] A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults
    Pezzolo, Elena
    Sechi, Andrea
    Tartaglia, Jacopo
    Naldi, Luigi
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (03) : 255 - 266
  • [23] Validation of the pruritus and symptoms assessment for atopic dermatitis in adults with moderate-to-severe atopic dermatitis
    Lebwohl, M. G.
    Simpson, E. L.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Gooderham, M. J.
    Wollenberg, A.
    Hall, R.
    Gater, A.
    Wells, J. R.
    Papacharalambous, J.
    Hsu, M. A.
    Tallman, A. M.
    Peeva, E.
    Zhang, W.
    Chen, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : E44 - E44
  • [24] Dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kraft, Magdalena
    Worm, Margitta
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (04) : 301 - 310
  • [25] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
    James E. Frampton
    Hannah A. Blair
    American Journal of Clinical Dermatology, 2018, 19 : 617 - 624
  • [26] Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Villegas, Susan C.
    Dima, Lorena
    AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (02) : E117 - E125
  • [27] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Diana Bernardo
    Thomas Bieber
    Tiago Torres
    American Journal of Clinical Dermatology, 2023, 24 : 753 - 764
  • [28] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
    Frampton, James E.
    Blair, Hannah A.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (04) : 617 - 624
  • [29] An evaluation of abrocitinib for moderate-to-severe atopic dermatitis
    Labib, Angelina
    Yosipovitch, Gil
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (11) : 1107 - 1118
  • [30] Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis
    Devjani, Shivali
    Engel, Priya, V
    Javadi, Sogol S.
    Smith, Brandon
    Wu, Jashin J.
    LANCET, 2023, 402 (10415): : 1833 - 1834
12345